Biotech

All Articles

Gene editor Tome laying off 131 employees

.Just days after gene editor Tome Biosciences declared hidden working slices, a more clear image is ...

Repare gives up 25% of staff as biotech standstills preclinical R&ampD

.Repare Therapeutics is giving up an one-fourth of its workforce as the oncology biotech lessen its ...

J &amp J files for FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually gotten yet another action towards recognizing a yield on its own ...

Gain's period 1 succeed paves method to verify Parkinson's drug's worth

.Gain Therapies has actually established its sights on verifying the efficiency of its Parkinson's c...

Actinogen records brand-new phase 2 data to recover anxiety medicine

.Actinogen Medical's chances-- and also stock price-- have recoiled a little from previously this mo...

Pfizer as well as Flagship incorporate Quotient to multibillion-dollar formula

.Crown Jewel Pioneering as well as Pfizer have added Quotient in to their 10-program relationship, i...

Bayer pens $547M contract to push borders of noncoding RNA

.Bayer executives were eager to worry to Strong this summer season that the German pharma titan's hu...

UK reveals strategies to release 18 brand new professional test centers

.Amidst a yearslong clinical trial decline in the U.K., a brand-new public-private partnership has a...

UPDATE: Genentech telegrams 93 unemployments in The golden state after sharing strategies to shutter cancer cells immunology analysis system

.Adhering to the announcement of a big layoff shot in April and a significant restructuring effort i...

Neurocrine's KarXT opponent strikes in stage 2-- but simply at low dosage

.Neurocrine Biosciences has actually achieved its hoped-for account in a period 2 schizophrenia test...